Table 4.
DEMOGRAPHICS | CC+ (n=22, 6%) | CC− (n=369, 94%) | p |
---|---|---|---|
| |||
Age (years) | 48 (29, 61) | 34 (25, 51) | 0.09 |
| |||
Male (n, %) | 19 (86%) | 259 (70%) | 0.10 |
| |||
Injury type (n, %) | 0.52 | ||
Blunt only | 15 (68%) | 286 (77%) | |
Penetrating only | 7 (32%) | 81 (22%) | |
Both | 0 (0%) | 3 (1%) | |
| |||
ISS | 30 (25, 38) | 19 (9, 29) | <0.001 |
| |||
PREHOSPITAL FLUIDS | |||
| |||
Crystalloid infusion (ml) | 0 (0, 300) | 0 (0, 270) | 0.78 |
| |||
Transfused prehospital RBCs (n, %) | 0 (0, 1) | 0 (0, 0) | 0.03 |
| |||
Transfused prehospital plasma (n, %) | 1 (0, 1) | 0 (0, 0) | <0.01 |
| |||
ED | |||
| |||
Systolic blood pressure (mm Hg) | 102 (80, 130) | 120 (102, 140) | 0.02 |
| |||
Heart rate (bpm) | 108 (89, 129) | 102 (86, 122) | 0.36 |
| |||
pH | 7.20 (6.99, 7.31) | 7.27 (7.21, 7.35) | <0.01 |
| |||
Base excess (mEq/L) | −6 (−13, −4) | −4 (−7, −1) | 0.01 |
| |||
Hemoglobin (g/dL) | 12.4 (10.5, 13.0) | 13.6 (12.1, 14.8) | <0.01 |
| |||
Platelet count (x 109/L) | 180 (127, 258) | 240 (192, 290) | <0.01 |
| |||
Emergent (≤90 minutes) OR or IR (n, %) | 13 (59%) | 70 (19%) | <0.001 |
| |||
OUTCOMES | |||
| |||
Total blood products at 4 hours (units) | 28 (8, 60) | 0 (0, 4) | <0.001 |
| |||
Total blood products at 24 hours (units) | 37 (9, 70) | 0 (0, 6) | <0.001 |
| |||
Death at 4 hours (n, %) | 5 (23%) | 9 (2%) | <0.001 |
| |||
Death at 24 hours (n, %) | 12 (55%) | 20 (5%) | <0.001 |
| |||
Death at 30 days (n, %) | 18 (82%) | 43 (12%) | <0.001 |
| |||
Primary cause of death | |||
| |||
Exsanguination (n, %) | 5 (23%) | 2 (<1%) | <0.001 |
| |||
TBI (n, %) | 12 (55%) | 35 (9%) | <0.001 |
| |||
Sepsis/MOF (n, %) | 1 (5%) | 2 (<1%) | 0.16 |
| |||
Other/Unknown (n, %) | 0 (0%) | 4 (1%) | 1.00 |
ISS, injury severity score; GCS, Glasgow coma score; TBI, traumatic brain injury; MOF, multiple organ failure.